Novozymes A/S

OTC: NVZMY · Real-Time Price · USD
65.22
-0.62 (-0.94%)
At close: Aug 14, 2025, 3:59 PM
65.20
-0.03%
After-hours: Aug 14, 2025, 04:00 PM EDT

Novozymes A/S Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
280M 1.12B 1.04B 963M
Short-Term Investments
4M 40M 80M 75M
Long-Term Investments
38.7M 205M 235M -16M
Other Long-Term Assets
10M 41.64M 112M 114M
Receivables
804.6M 3.77B 3.6B 2.99B
Inventory
720.6M 3.63B 3.8B 2.99B
Other Current Assets
70.2M 947M 618M 880M
Total Current Assets
1.88B 9.46B 9.24B 7.82B
Property-Plant & Equipment
2.97B 12.32B 12.07B 10.19B
Goodwill & Intangibles
10.02B 4.53B 4.7B 5.02B
Total Long-Term Assets
13.32B 18.93B 18.74B 16.94B
Total Assets
15.2B 28.39B 27.98B 24.77B
Account Payables
423.1M 1.62B 1.87B 1.49B
Deferred Revenue
n/a n/a 138M 163M
Short-Term Debt
266.4M 3.04B 2.92B 1.98B
Other Current Liabilities
337.9M 1.65B 1.36B 3.21B
Total Current Liabilities
1.09B 7.26B 6.96B 5.67B
Long-Term Debt
1.53B 4.33B 3.62B n/a
Other Long-Term Liabilities
39.7M 2.42B 2.88B 6.53B
Total Long-Term Liabilities
2.93B 6.78B 6.79B 6.89B
Total Liabilities
4.02B 14.04B 13.76B 12.56B
Total Debt
1.8B 7.73B 411M 482M
Common Stock
125.6M 562M 562M 564M
Retained Earnings
11.03B 13.76B 13.06B 11.3B
Comprehensive Income
n/a -339M 213M -40M
Shareholders Equity
11.18B 13.98B 13.84B 11.83B
Total Investments
42.7M 267M 315M 59M